- Home
- NRXS vs RMCO Comparison
NRXS vs RMCO Comparison
Compare NRXS & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXS
- RMCO
- Stock Information
- Founded
- NRXS 2011
- RMCO 2021
- Country
- NRXS United States
- RMCO United States
- Employees
- NRXS N/A
- RMCO N/A
- Industry
- NRXS
- RMCO Multi-Sector Companies
- Sector
- NRXS
- RMCO Miscellaneous
- Exchange
- NRXS Nasdaq
- RMCO Nasdaq
- Market Cap
- NRXS 17.3M
- RMCO 14.8M
- IPO Year
- NRXS 2023
- RMCO N/A
- Fundamental
- Price
- NRXS $2.42
- RMCO $1.05
- Analyst Decision
- NRXS
- RMCO
- Analyst Count
- NRXS 0
- RMCO 0
- Target Price
- NRXS N/A
- RMCO N/A
- AVG Volume (30 Days)
- NRXS 25.4K
- RMCO 22.2K
- Earning Date
- NRXS 11-12-2024
- RMCO 01-24-2025
- Dividend Yield
- NRXS N/A
- RMCO N/A
- EPS Growth
- NRXS N/A
- RMCO N/A
- EPS
- NRXS N/A
- RMCO N/A
- Revenue
- NRXS $2,456,219.00
- RMCO $568,896.00
- Revenue This Year
- NRXS $383.16
- RMCO N/A
- Revenue Next Year
- NRXS N/A
- RMCO N/A
- P/E Ratio
- NRXS N/A
- RMCO N/A
- Revenue Growth
- NRXS N/A
- RMCO 21.05
- 52 Week Low
- NRXS $2.00
- RMCO $0.70
- 52 Week High
- NRXS $3.89
- RMCO $4.75
- Technical
- Relative Strength Index (RSI)
- NRXS 42.11
- RMCO 52.39
- Support Level
- NRXS $2.72
- RMCO $0.96
- Resistance Level
- NRXS $2.77
- RMCO $1.09
- Average True Range (ATR)
- NRXS 0.43
- RMCO 0.10
- MACD
- NRXS -0.05
- RMCO 0.01
- Stochastic Oscillator
- NRXS 12.71
- RMCO 46.15
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About RMCO Royalty Management Holding Corporation
Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.